MIMS CDS footer logo
  • Home
  • Solutions
    • MIMS Integrated
    • eMIMSplus
  • Practices
    • Hospitals
    • Pharmacies
    • Clinics
    • Telemedicine
    • Become A Partner
  • Learn More
    • Editorial Process
    • Testimonials
    • FAQs
    • Contact Support
  • Blog
  • CONTACT US

Clinically Significant Drug Interactions with Grapefruit: What Prescribers Need to Know

by MIMS CDS Asia | Nov 10, 2025 | Articles

4 minutes read time Grapefruit is often praised for its nutritional value, but for patients on certain medications, this seemingly harmless fruit may pose an avoidable risk. Although grapefruit-drug interactions are well-documented in literature, these risks remain...

Polypharmacy and Hyperglycaemia Risk in Patients with Diabetes

by MIMS CDS Asia | Sep 22, 2025 | Articles

6 minutes read time Type 2 diabetes mellitus (T2DM) is a progressive metabolic disorder characterised by chronic hyperglycaemia resulting from a combination of insulin resistance and impaired insulin secretion. Management of T2DM commonly involves lifestyle...

Implementing Clinical Decision Support System (CDSS): A Path to Success

by MIMS CDS Asia | Sep 8, 2025 | Articles

5 minutes read time CDSS (Clinical Decision Support System) have become indispensable tools in today’s evolving healthcare landscape, helping improve patient care, reduce errors, and enhance outcomes. This article outlines the key steps healthcare organisations should...

Paracetamol Use in NSAID-Allergic Patients – Are You Overlooking the Cross-Sensitivity Risk?

by MIMS CDS Asia | Aug 4, 2025 | Articles

5 minutes read time Paracetamol is widely used and often assumed to be a safe alternative in patients with nonsteroidal anti-inflammatory drug (NSAID) hypersensitivity. However, emerging evidence indicates that cross-reactivity between paracetamol and NSAIDs can occur...

Preventing Serotonin Syndrome with Clinical Decision Solutions: A Safety Imperative in Psychiatry

by MIMS CDS Asia | Jul 7, 2025 | Articles

5 minutes read time Patients are often treated with complex, multi-drug regimens involving serotonergic agents in today’s healthcare landscape. While these combinations are necessary for managing conditions like depression, anxiety, and psychosis, they increase the...
« Older Entries
Next Entries »

Recent Posts

  • Selective Serotonin Reuptake Inhibitors (SSRIs) and the Risk of Bleeding
  • St John’s Wort: Clinically Important Drug Interactions
  • Enzyme-Inducing Antiepileptic Drugs and the Risk of Vitamin D Deficiency
  • Understanding Hypoglycaemia Risks in Diabetes from Polypharmacy Practices
  • From Errors to Efficiency: Why Hospitals Can’t Afford to Skip Medication Safety
MIMS CDS footer logo

Safer Medications, Better Care.

  • Follow
  • Follow
Navigate
Solutions
– MIMS Integrated
– eMIMSplus
Hospitals
Pharmacies
Clinics
Blog
Editorial Process
Testimonials
FAQs
Become a Partner
Contact Us
Get In Touch


Sales

cdssales@mims.com



Support

cdssupport@mims.com



Regional Headquarters

438B Alexandra Rd, Alexandra Technopark, #06-11 Singapore 119968
Copyright © 2026 MIMS CDS Asia | Privacy Policy